Search Results 1681-1690 of 13597 for 📏加🍌line:sammibaby🍌了解力曼直銷🐫很瘦平胸怎麼豐胸🍛產後營養瘦身🎗新竹市腹肌贴有用吗🏷新兴区win7瘦身🛩️暴走多久才有減肥效果🐫kitty强力瘦身操2😘力量直銷
Learn about this cancer that forms in the bones and the connective tissue. Find out about symptoms, diagnosis, treatment and the many types of sarcoma.
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies. Scottsdale/Phoenix, Ariz. This is a Phase 1, open-label, ...
This is a Phase II, multicenter, open-label, single arm, 2-stage study of tazemetostat 800 mg BID administered orally in continuous 28 day cycles. Screening ...
Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...
Rochester, Minn., Mankato, Minn., Albert Lea, Minn. This trial will be an evaluation of rose geranium in sesame oil nasal spray versus nasal saline. Rose ...
Study CRB-402 is a 2-part, non-randomized, open label, multi-site Phase 1 study of bb21217 in adults with relapsed/refractory multiple myeloma (MM).
Rochester, Minn. This is a Phase 1b, open label, multi-center study of CMB305 (sequentially administered LV305 [a dendritic cell-targeting viral vector ...
Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients. Rochester, Minn. The study is a multicenter, open label Phase I/II trial. 1. Establish the MTD ...
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma. Rochester, Minn. This is a Phase 2, multicenter, open-label, 2-part, single-arm, 2- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.